Stemnovate Limited
PrivateLast Round
Crowdfunding
Feb 1, 2026
Est. Valuation
$40.23M
Total Funding Raised
$3.63M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stemnovate Limited operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a Crowdfunding round in February 2026.
Stemnovate Limited is a biotechnology company that provides a next-generation drug discovery platform combining stem cell technology, molecular sciences, and microengineering to accelerate clinical translation and reduce reliance on animal testing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stemnovate Limited Comparables
Compare Stemnovate Limited with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axol Bioscience | 91% | |
| Ncardia | 86% | |
| bit.bio | 81% |
For institutional investors. Book with your work email.
Stemnovate Limited Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Feb 1, 2026 | ||||
| Angel | Aug 4, 2022 | ||||
| Seed | Jul 29, 2019 | ||||
| Seed | May 25, 2018 | ||||
| Grant | Sep 1, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stemnovate Limited Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| o2h ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 5, 2026
Added University of the West of England as an enterprise customer.
- Jun 5, 2026
Added St George's, University of London as a customer.
For institutional investors. Book with your work email.
Stemnovate Limited Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stemnovate Limited's valuation, stock price, and market status.
Is Stemnovate Limited a public or private company?
Stemnovate Limited is a private company.
What is the current stock price of Stemnovate Limited?
Stemnovate Limited is a private company, so its shares have no public market price. Caplight tracks Stemnovate Limited's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stemnovate Limited worth (valuation)?
Stemnovate Limited's valuation is estimated at $40.2M based on funding round data.
Can I buy Stemnovate Limited stock?
Stemnovate Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stemnovate Limited's last funding round?
Stemnovate Limited's most recent funding round was Crowdfunding on February 1, 2026.
Who are the main investors in Stemnovate Limited?
Key investors in Stemnovate Limited include o2h ventures.
Will Stemnovate Limited IPO soon?
No public IPO plans have been announced for Stemnovate Limited.
How can I track Stemnovate Limited secondary market activity?
Caplight tracks bids, offers, and trades in Stemnovate Limited's shares on secondary markets.